Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy
…, H Yurino, N Monma, H Xiang, K Sumida… - Cancer …, 2017 - Wiley Online Library
۱۰۱ ارجاع2017
Conquering immunosuppression in tumor microenvironments is crucial for effective cancer immunotherapy. It is well known that interleukin ( IL )‐6, a pleiotropic cytokine, is produced in …